Immunotherapy is a new direction in tumor treatment, and immune checkpoint blockade is the main target of tumor immunotherapy, while PD1/PD-L1 immune checkpoint blockade is a hot spot in immunotherapy research [37,38]. Here, CD274 is linked to neoplasm.